Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · S 4885

Shandra Eisenga Human Cell and Tissue Product Safety Act

Refreshed 3 h ago

Introduced 2026-06-24Topic: health care · public health

Summary

AI-generated summary, report an error

This bill would require the Secretary of Health and Human Services to support educational materials for health care professionals about organ, tissue, and eye donation and donor screening tests. It would create civil penalties for people who violate certain federal rules on human cell and tissue products, up to $20,000 per violation plus the retail value of the products, with a $10 million cap per proceeding. The Food and Drug Administration would have to publish information online about its Tissue Reference Group, registrations and inspections of tissue establishments, and response times, and hold workshops for stakeholders. The Secretary would also open a public comment docket on modernizing these rules and send recommendations to Congress.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-06-24SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.refer
2026-06-24Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.